Figure 3
From: A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
ROC analysis of APAR for HCC diagnosis. AUC of APAR for predicting HCC in (A) HCC versus non-cancer control in the training set, (B) HCC versus CHB in the training set, (C) HCC versus non-cancer control in the validation set, (D) HCC versus CHB in the validation set, (E) HCC versus non-cancer control in the whole set of participants of low or normal AFP (<100 ng/mL), (F) HCC versus CHB in the whole set of participants of low or normal AFP (<100 ng/mL), (G) HCC versus non-cancer control in the whole set of participants of normal AFP (<20 ng/mL), (H) HCC versus CHB in the whole set of participants of normal AFP (<20 ng/mL).
